Report Detail
Global Targeted Antitumor Drugs Market Growth 2022-2028
- RnM4496141 |
- 02 December, 2022 |
- Global |
- 90 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Targeted antitumor drugs use specific structural molecules of tumor tissues or cells as targets to achieve the purpose of directly killing tumor cells, and have the advantages of high specificity, high selectivity, light side reactions and high efficacy/toxicity ratio compared with chemotherapy drugs
The global market for Targeted Antitumor Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Targeted Antitumor Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Targeted Antitumor Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Targeted Antitumor Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Targeted Antitumor Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Targeted Antitumor Drugs players cover Roche, Celgene, Novartis, Johnson & Johnson and Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Targeted Antitumor Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Targeted Antitumor Drugs market, with both quantitative and qualitative data, to help readers understand how the Targeted Antitumor Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Targeted Antitumor Drugs market and forecasts the market size by Type (Macromolecular Targeted Antitumor Drugs and Small Molecule Targeted Antitumor Drugs,), by Application (Lung Cancer, Lymphoma, Breast Cancer and Leukaemia), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Macromolecular Targeted Antitumor Drugs
Small Molecule Targeted Antitumor Drugs
Segmentation by application
Lung Cancer
Lymphoma
Breast Cancer
Leukaemia
Prostate Cancer
Multiple Bone Marrow Cancer
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Roche
Celgene
Novartis
Johnson & Johnson
Lilly
AstraZeneca plc.
Betta Pharmaceuticals
Chapter Introduction
Chapter 1: Scope of Targeted Antitumor Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Targeted Antitumor Drugs market size (sales and revenue) and CAGR, Targeted Antitumor Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Targeted Antitumor Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Targeted Antitumor Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Targeted Antitumor Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Roche, Celgene, Novartis, Johnson & Johnson, Lilly, AstraZeneca plc. and Betta Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Targeted Antitumor Drugs Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Targeted Antitumor Drugs by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Targeted Antitumor Drugs by Country/Region, 2017, 2022 & 2028
- 2.2 Targeted Antitumor Drugs Segment by Type
- 2.2.1 Macromolecular Targeted Antitumor Drugs
- 2.2.2 Small Molecule Targeted Antitumor Drugs
- 2.3 Targeted Antitumor Drugs Sales by Type
- 2.3.1 Global Targeted Antitumor Drugs Sales Market Share by Type (2017-2022)
- 2.3.2 Global Targeted Antitumor Drugs Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Targeted Antitumor Drugs Sale Price by Type (2017-2022)
- 2.4 Targeted Antitumor Drugs Segment by Application
- 2.4.1 Lung Cancer
- 2.4.2 Lymphoma
- 2.4.3 Breast Cancer
- 2.4.4 Leukaemia
- 2.4.5 Prostate Cancer
- 2.4.6 Multiple Bone Marrow Cancer
- 2.4.7 Others
- 2.5 Targeted Antitumor Drugs Sales by Application
- 2.5.1 Global Targeted Antitumor Drugs Sale Market Share by Application (2017-2022)
- 2.5.2 Global Targeted Antitumor Drugs Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Targeted Antitumor Drugs Sale Price by Application (2017-2022)
3 Global Targeted Antitumor Drugs by Company
- 3.1 Global Targeted Antitumor Drugs Breakdown Data by Company
- 3.1.1 Global Targeted Antitumor Drugs Annual Sales by Company (2020-2022)
- 3.1.2 Global Targeted Antitumor Drugs Sales Market Share by Company (2020-2022)
- 3.2 Global Targeted Antitumor Drugs Annual Revenue by Company (2020-2022)
- 3.2.1 Global Targeted Antitumor Drugs Revenue by Company (2020-2022)
- 3.2.2 Global Targeted Antitumor Drugs Revenue Market Share by Company (2020-2022)
- 3.3 Global Targeted Antitumor Drugs Sale Price by Company
- 3.4 Key Manufacturers Targeted Antitumor Drugs Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Targeted Antitumor Drugs Product Location Distribution
- 3.4.2 Players Targeted Antitumor Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Targeted Antitumor Drugs by Geographic Region
- 4.1 World Historic Targeted Antitumor Drugs Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Targeted Antitumor Drugs Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Targeted Antitumor Drugs Annual Revenue by Geographic Region
- 4.2 World Historic Targeted Antitumor Drugs Market Size by Country/Region (2017-2022)
- 4.2.1 Global Targeted Antitumor Drugs Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Targeted Antitumor Drugs Annual Revenue by Country/Region
- 4.3 Americas Targeted Antitumor Drugs Sales Growth
- 4.4 APAC Targeted Antitumor Drugs Sales Growth
- 4.5 Europe Targeted Antitumor Drugs Sales Growth
- 4.6 Middle East & Africa Targeted Antitumor Drugs Sales Growth
5 Americas
- 5.1 Americas Targeted Antitumor Drugs Sales by Country
- 5.1.1 Americas Targeted Antitumor Drugs Sales by Country (2017-2022)
- 5.1.2 Americas Targeted Antitumor Drugs Revenue by Country (2017-2022)
- 5.2 Americas Targeted Antitumor Drugs Sales by Type
- 5.3 Americas Targeted Antitumor Drugs Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Targeted Antitumor Drugs Sales by Region
- 6.1.1 APAC Targeted Antitumor Drugs Sales by Region (2017-2022)
- 6.1.2 APAC Targeted Antitumor Drugs Revenue by Region (2017-2022)
- 6.2 APAC Targeted Antitumor Drugs Sales by Type
- 6.3 APAC Targeted Antitumor Drugs Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Targeted Antitumor Drugs by Country
- 7.1.1 Europe Targeted Antitumor Drugs Sales by Country (2017-2022)
- 7.1.2 Europe Targeted Antitumor Drugs Revenue by Country (2017-2022)
- 7.2 Europe Targeted Antitumor Drugs Sales by Type
- 7.3 Europe Targeted Antitumor Drugs Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Targeted Antitumor Drugs by Country
- 8.1.1 Middle East & Africa Targeted Antitumor Drugs Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Targeted Antitumor Drugs Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Targeted Antitumor Drugs Sales by Type
- 8.3 Middle East & Africa Targeted Antitumor Drugs Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Targeted Antitumor Drugs
- 10.3 Manufacturing Process Analysis of Targeted Antitumor Drugs
- 10.4 Industry Chain Structure of Targeted Antitumor Drugs
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Targeted Antitumor Drugs Distributors
- 11.3 Targeted Antitumor Drugs Customer
12 World Forecast Review for Targeted Antitumor Drugs by Geographic Region
- 12.1 Global Targeted Antitumor Drugs Market Size Forecast by Region
- 12.1.1 Global Targeted Antitumor Drugs Forecast by Region (2023-2028)
- 12.1.2 Global Targeted Antitumor Drugs Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Targeted Antitumor Drugs Forecast by Type
- 12.7 Global Targeted Antitumor Drugs Forecast by Application
13 Key Players Analysis
- 13.1 Roche
- 13.1.1 Roche Company Information
- 13.1.2 Roche Targeted Antitumor Drugs Product Offered
- 13.1.3 Roche Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Roche Main Business Overview
- 13.1.5 Roche Latest Developments
- 13.2 Celgene
- 13.2.1 Celgene Company Information
- 13.2.2 Celgene Targeted Antitumor Drugs Product Offered
- 13.2.3 Celgene Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Celgene Main Business Overview
- 13.2.5 Celgene Latest Developments
- 13.3 Novartis
- 13.3.1 Novartis Company Information
- 13.3.2 Novartis Targeted Antitumor Drugs Product Offered
- 13.3.3 Novartis Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Novartis Main Business Overview
- 13.3.5 Novartis Latest Developments
- 13.4 Johnson & Johnson
- 13.4.1 Johnson & Johnson Company Information
- 13.4.2 Johnson & Johnson Targeted Antitumor Drugs Product Offered
- 13.4.3 Johnson & Johnson Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Johnson & Johnson Main Business Overview
- 13.4.5 Johnson & Johnson Latest Developments
- 13.5 Lilly
- 13.5.1 Lilly Company Information
- 13.5.2 Lilly Targeted Antitumor Drugs Product Offered
- 13.5.3 Lilly Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Lilly Main Business Overview
- 13.5.5 Lilly Latest Developments
- 13.6 AstraZeneca plc.
- 13.6.1 AstraZeneca plc. Company Information
- 13.6.2 AstraZeneca plc. Targeted Antitumor Drugs Product Offered
- 13.6.3 AstraZeneca plc. Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 AstraZeneca plc. Main Business Overview
- 13.6.5 AstraZeneca plc. Latest Developments
- 13.7 Betta Pharmaceuticals
- 13.7.1 Betta Pharmaceuticals Company Information
- 13.7.2 Betta Pharmaceuticals Targeted Antitumor Drugs Product Offered
- 13.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Betta Pharmaceuticals Main Business Overview
- 13.7.5 Betta Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Targeted Antitumor Drugs. Industry analysis & Market Report on Targeted Antitumor Drugs is a syndicated market report, published as Global Targeted Antitumor Drugs Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Targeted Antitumor Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
